Experimental DME pill trial ends early after just one volunteer
NCT ID NCT06781255
First seen Apr 09, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This early-stage study tested the safety of an oral drug called K9 for diabetic macular edema, a condition that causes vision loss in people with diabetes. Only one person took part before the trial was stopped. The goal was to see if the drug caused side effects and if it improved vision or reduced swelling in the eye.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.